HEADER MEMBRANE PROTEIN 31-JAN-14 4OO9 TITLE STRUCTURE OF THE HUMAN CLASS C GPCR METABOTROPIC GLUTAMATE RECEPTOR 5 TITLE 2 TRANSMEMBRANE DOMAIN IN COMPLEX WITH THE NEGATIVE ALLOSTERIC TITLE 3 MODULATOR MAVOGLURANT COMPND MOL_ID: 1; COMPND 2 MOLECULE: METABOTROPIC GLUTAMATE RECEPTOR 5, LYSOZYME, METABOTROPIC COMPND 3 GLUTAMATE RECEPTOR 5 CHIMERA; COMPND 4 CHAIN: A; COMPND 5 FRAGMENT: SEE REMARK 999; COMPND 6 SYNONYM: MGLUR5, ENDOLYSIN, LYSIS PROTEIN, MURAMIDASE; COMPND 7 EC: 3.2.1.17; COMPND 8 ENGINEERED: YES; COMPND 9 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS, ENTEROBACTERIA PHAGE T4; SOURCE 3 ORGANISM_COMMON: HUMAN, T4 PHAGE, HUMAN; SOURCE 4 ORGANISM_TAXID: 9606, 10665; SOURCE 5 GENE: GRM5, GPRC1E, MGLUR5, E; SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 7 EXPRESSION_SYSTEM_COMMON: FALL ARMYWORM; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 7108; SOURCE 9 EXPRESSION_SYSTEM_STRAIN: SF21; SOURCE 10 EXPRESSION_SYSTEM_VECTOR_TYPE: BACULOVIRUS; SOURCE 11 EXPRESSION_SYSTEM_PLASMID: FASTBAC KEYWDS 7TM, RECEPTOR, G-PROTEIN, CYSTEINE-S-ACETAMIDE, MEMBRANE PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR A.S.DORE,K.OKRASA,J.C.PATEL,M.SERRANO-VEGA,K.BENNETT,R.M.COOKE, AUTHOR 2 J.C.ERREY,A.JAZAYERI,S.KHAN,B.TEHAN,M.WEIR,G.R.WIGGIN,F.H.MARSHALL REVDAT 7 20-SEP-23 4OO9 1 REMARK SEQADV LINK REVDAT 6 26-JUL-17 4OO9 1 SOURCE REMARK REVDAT 5 15-JUL-15 4OO9 1 SOURCE REVDAT 4 06-AUG-14 4OO9 1 JRNL REVDAT 3 16-JUL-14 4OO9 1 ATOM COMPND DBREF HETNAM REVDAT 3 2 1 HETSYN REMARK SOURCE REVDAT 2 09-JUL-14 4OO9 1 JRNL REVDAT 1 02-JUL-14 4OO9 0 JRNL AUTH A.S.DORE,K.OKRASA,J.C.PATEL,M.SERRANO-VEGA,K.BENNETT, JRNL AUTH 2 R.M.COOKE,J.C.ERREY,A.JAZAYERI,S.KHAN,B.TEHAN,M.WEIR, JRNL AUTH 3 G.R.WIGGIN,F.H.MARSHALL JRNL TITL STRUCTURE OF CLASS C GPCR METABOTROPIC GLUTAMATE RECEPTOR 5 JRNL TITL 2 TRANSMEMBRANE DOMAIN. JRNL REF NATURE V. 511 557 2014 JRNL REFN ISSN 0028-0836 JRNL PMID 25042998 JRNL DOI 10.1038/NATURE13396 REMARK 2 REMARK 2 RESOLUTION. 2.60 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (PHENIX.REFINE: 1.8.1_1168) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.60 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 29.74 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.350 REMARK 3 COMPLETENESS FOR RANGE (%) : 94.1 REMARK 3 NUMBER OF REFLECTIONS : 14779 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.241 REMARK 3 R VALUE (WORKING SET) : 0.239 REMARK 3 FREE R VALUE : 0.275 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.680 REMARK 3 FREE R VALUE TEST SET COUNT : 691 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 29.7415 - 4.4420 0.90 2768 148 0.2093 0.2374 REMARK 3 2 4.4420 - 3.5276 0.94 2813 141 0.2213 0.2630 REMARK 3 3 3.5276 - 3.0822 0.95 2851 131 0.2615 0.3285 REMARK 3 4 3.0822 - 2.8006 0.96 2855 140 0.2780 0.2635 REMARK 3 5 2.8006 - 2.6000 0.95 2801 131 0.3078 0.3762 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.10 REMARK 3 SHRINKAGE RADIUS : 0.70 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.350 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 30.750 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 43.00 REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.003 3373 REMARK 3 ANGLE : 0.658 4555 REMARK 3 CHIRALITY : 0.043 526 REMARK 3 PLANARITY : 0.003 551 REMARK 3 DIHEDRAL : 11.531 1280 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 3 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: CHAIN 'A' AND (RESID 568 THROUGH 640 ) REMARK 3 ORIGIN FOR THE GROUP (A): -33.6069 -13.9594 41.1170 REMARK 3 T TENSOR REMARK 3 T11: 0.2019 T22: 0.1974 REMARK 3 T33: 0.2147 T12: -0.0650 REMARK 3 T13: -0.0220 T23: -0.0046 REMARK 3 L TENSOR REMARK 3 L11: 0.3076 L22: 0.1018 REMARK 3 L33: 0.0372 L12: 0.1014 REMARK 3 L13: 0.2672 L23: 0.0489 REMARK 3 S TENSOR REMARK 3 S11: -0.1043 S12: 0.0604 S13: -0.2340 REMARK 3 S21: 0.1240 S22: 0.0169 S23: 0.2486 REMARK 3 S31: 0.1873 S32: 0.0725 S33: 0.0231 REMARK 3 TLS GROUP : 2 REMARK 3 SELECTION: CHAIN 'A' AND (RESID 641 THROUGH 689 ) OR CHAIN 'A' REMARK 3 AND (RESID 1002 THROUGH 1162 ) REMARK 3 ORIGIN FOR THE GROUP (A): -14.3547 4.2183 7.9223 REMARK 3 T TENSOR REMARK 3 T11: 0.1429 T22: 0.3198 REMARK 3 T33: 0.1618 T12: 0.0647 REMARK 3 T13: 0.0111 T23: -0.0299 REMARK 3 L TENSOR REMARK 3 L11: -0.2527 L22: 0.2104 REMARK 3 L33: 0.5866 L12: 0.2064 REMARK 3 L13: -0.1660 L23: -0.0684 REMARK 3 S TENSOR REMARK 3 S11: -0.1206 S12: -0.1167 S13: -0.0101 REMARK 3 S21: 0.0021 S22: 0.0662 S23: -0.0498 REMARK 3 S31: -0.1231 S32: -0.2951 S33: -0.1222 REMARK 3 TLS GROUP : 3 REMARK 3 SELECTION: CHAIN 'A' AND (RESID 690 THROUGH 832 ) REMARK 3 ORIGIN FOR THE GROUP (A): -22.7584 -5.6735 38.5019 REMARK 3 T TENSOR REMARK 3 T11: 0.1870 T22: 0.1195 REMARK 3 T33: 0.1967 T12: -0.0287 REMARK 3 T13: -0.0043 T23: 0.0109 REMARK 3 L TENSOR REMARK 3 L11: 0.5221 L22: 0.2787 REMARK 3 L33: 0.2468 L12: -0.2132 REMARK 3 L13: 0.1409 L23: -0.1073 REMARK 3 S TENSOR REMARK 3 S11: -0.0313 S12: -0.0197 S13: -0.0149 REMARK 3 S21: 0.0105 S22: -0.0414 S23: -0.0331 REMARK 3 S31: 0.0518 S32: -0.0183 S33: -0.0498 REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 4OO9 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 06-FEB-14. REMARK 100 THE DEPOSITION ID IS D_1000084742. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 06-DEC-13 REMARK 200 TEMPERATURE (KELVIN) : 200 REMARK 200 PH : 6.8 REMARK 200 NUMBER OF CRYSTALS USED : 5 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : DIAMOND REMARK 200 BEAMLINE : I24 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.96861 REMARK 200 MONOCHROMATOR : DOUBLE CRYSTAL SI(111) REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : AIMLESS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 14800 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.600 REMARK 200 RESOLUTION RANGE LOW (A) : 80.955 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 1.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 94.9 REMARK 200 DATA REDUNDANCY : 2.700 REMARK 200 R MERGE (I) : 0.11600 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 7.4000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.60 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.72 REMARK 200 COMPLETENESS FOR SHELL (%) : 94.8 REMARK 200 DATA REDUNDANCY IN SHELL : 2.60 REMARK 200 R MERGE FOR SHELL (I) : 0.75400 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 1.800 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: PDB ENTRIES 3EML, 3UON, 4DAJ, 4DKL, 4DJH, 3V2Y, REMARK 200 4EA3, AND 1U19 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 51.37 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.53 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 24-34% V/V PEG400, 0.2 M AMMONIUM REMARK 280 PHOSPHATE DIBASIC, 0.1 M MES, PH 6.8, LIPIDIC CUBIC PHASE, REMARK 280 TEMPERATURE 293.1K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 71.62100 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 21.77750 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 71.62100 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 21.77750 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH A4143 LIES ON A SPECIAL POSITION. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ALA A 566 REMARK 465 ALA A 567 REMARK 465 CYS A 681 REMARK 465 THR A 682 REMARK 465 LYS A 683 REMARK 465 LYS A 684 REMARK 465 PRO A 685 REMARK 465 ARG A 686 REMARK 465 PHE A 687 REMARK 465 MET A 688 REMARK 465 HIS A 721 REMARK 465 ASP A 722 REMARK 465 TYR A 723 REMARK 465 PRO A 724 REMARK 465 SER A 725 REMARK 465 ILE A 726 REMARK 465 ARG A 727 REMARK 465 GLU A 728 REMARK 465 VAL A 833 REMARK 465 ARG A 834 REMARK 465 SER A 835 REMARK 465 ALA A 836 REMARK 465 ALA A 837 REMARK 465 ALA A 838 REMARK 465 ALA A 839 REMARK 465 HIS A 840 REMARK 465 HIS A 841 REMARK 465 HIS A 842 REMARK 465 HIS A 843 REMARK 465 HIS A 844 REMARK 465 HIS A 845 REMARK 465 HIS A 846 REMARK 465 HIS A 847 REMARK 465 HIS A 848 REMARK 465 HIS A 849 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O GLU A 1011 O HOH A 4142 2.16 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PRO A 639 92.50 -69.69 REMARK 500 REMARK 500 REMARK: NULL REMARK 610 REMARK 610 MISSING HETEROATOM REMARK 610 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 610 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 610 I=INSERTION CODE): REMARK 610 M RES C SSEQI REMARK 610 OLA A 4002 REMARK 610 OLA A 4003 REMARK 610 OLA A 4004 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE OLA A 4001 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE OLA A 4002 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE OLA A 4003 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE OLA A 4004 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 2U8 A 4005 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MES A 4006 REMARK 999 REMARK 999 SEQUENCE REMARK 999 PROTEIN IS A CHIMERA COMPRISING RESIDUES 569-678 AND 679-836 OF REMARK 999 GLUR5 SEPARATED BY RESIDUES 2-162 OF LYSOZYME. DBREF 4OO9 A 569 678 UNP P41594 GRM5_HUMAN 569 678 DBREF 4OO9 A 1002 1162 UNP P00720 LYS_BPT4 2 162 DBREF 4OO9 A 680 836 UNP P41594 GRM5_HUMAN 680 836 SEQADV 4OO9 ALA A 566 UNP P41594 EXPRESSION TAG SEQADV 4OO9 ALA A 567 UNP P41594 EXPRESSION TAG SEQADV 4OO9 SER A 568 UNP P41594 EXPRESSION TAG SEQADV 4OO9 ALA A 579 UNP P41594 GLU 579 ENGINEERED MUTATION SEQADV 4OO9 TYR A 667 UNP P41594 ASN 667 ENGINEERED MUTATION SEQADV 4OO9 ALA A 669 UNP P41594 ILE 669 ENGINEERED MUTATION SEQADV 4OO9 MET A 675 UNP P41594 GLY 675 ENGINEERED MUTATION SEQADV 4OO9 THR A 1054 UNP P00720 CYS 54 ENGINEERED MUTATION SEQADV 4OO9 ALA A 1097 UNP P00720 CYS 97 ENGINEERED MUTATION SEQADV 4OO9 ALA A 742 UNP P41594 THR 742 ENGINEERED MUTATION SEQADV 4OO9 ALA A 753 UNP P41594 SER 753 ENGINEERED MUTATION SEQADV 4OO9 ALA A 837 UNP P41594 EXPRESSION TAG SEQADV 4OO9 ALA A 838 UNP P41594 EXPRESSION TAG SEQADV 4OO9 ALA A 839 UNP P41594 EXPRESSION TAG SEQADV 4OO9 HIS A 840 UNP P41594 EXPRESSION TAG SEQADV 4OO9 HIS A 841 UNP P41594 EXPRESSION TAG SEQADV 4OO9 HIS A 842 UNP P41594 EXPRESSION TAG SEQADV 4OO9 HIS A 843 UNP P41594 EXPRESSION TAG SEQADV 4OO9 HIS A 844 UNP P41594 EXPRESSION TAG SEQADV 4OO9 HIS A 845 UNP P41594 EXPRESSION TAG SEQADV 4OO9 HIS A 846 UNP P41594 EXPRESSION TAG SEQADV 4OO9 HIS A 847 UNP P41594 EXPRESSION TAG SEQADV 4OO9 HIS A 848 UNP P41594 EXPRESSION TAG SEQADV 4OO9 HIS A 849 UNP P41594 EXPRESSION TAG SEQRES 1 A 444 ALA ALA SER PRO VAL GLN TYR LEU ARG TRP GLY ASP PRO SEQRES 2 A 444 ALA PRO ILE ALA ALA VAL VAL PHE ALA CYS LEU GLY LEU SEQRES 3 A 444 LEU ALA THR LEU PHE VAL THR VAL VAL PHE ILE ILE TYR SEQRES 4 A 444 ARG ASP THR PRO VAL VAL LYS SER SER SER ARG GLU LEU SEQRES 5 A 444 CYS TYR ILE ILE LEU ALA GLY ILE CYS LEU GLY TYR LEU SEQRES 6 A 444 CYS THR PHE YCM LEU ILE ALA LYS PRO LYS GLN ILE TYR SEQRES 7 A 444 CYS TYR LEU GLN ARG ILE GLY ILE GLY LEU SER PRO ALA SEQRES 8 A 444 MET SER TYR SER ALA LEU VAL THR LYS THR TYR ARG ALA SEQRES 9 A 444 ALA ARG ILE LEU ALA MET SER LYS LYS ASN ILE PHE GLU SEQRES 10 A 444 MET LEU ARG ILE ASP GLU GLY LEU ARG LEU LYS ILE TYR SEQRES 11 A 444 LYS ASP THR GLU GLY TYR TYR THR ILE GLY ILE GLY HIS SEQRES 12 A 444 LEU LEU THR LYS SER PRO SER LEU ASN ALA ALA LYS SER SEQRES 13 A 444 GLU LEU ASP LYS ALA ILE GLY ARG ASN THR ASN GLY VAL SEQRES 14 A 444 ILE THR LYS ASP GLU ALA GLU LYS LEU PHE ASN GLN ASP SEQRES 15 A 444 VAL ASP ALA ALA VAL ARG GLY ILE LEU ARG ASN ALA LYS SEQRES 16 A 444 LEU LYS PRO VAL TYR ASP SER LEU ASP ALA VAL ARG ARG SEQRES 17 A 444 ALA ALA LEU ILE ASN MET VAL PHE GLN MET GLY GLU THR SEQRES 18 A 444 GLY VAL ALA GLY PHE THR ASN SER LEU ARG MET LEU GLN SEQRES 19 A 444 GLN LYS ARG TRP ASP GLU ALA ALA VAL ASN LEU ALA LYS SEQRES 20 A 444 SER ARG TRP TYR ASN GLN THR PRO ASN ARG ALA LYS ARG SEQRES 21 A 444 VAL ILE THR THR PHE ARG THR GLY THR TRP ASP ALA TYR SEQRES 22 A 444 LYS ILE CYS THR LYS LYS PRO ARG PHE MET SER ALA YCM SEQRES 23 A 444 ALA GLN LEU VAL ILE ALA PHE ILE LEU ILE CYS ILE GLN SEQRES 24 A 444 LEU GLY ILE ILE VAL ALA LEU PHE ILE MET GLU PRO PRO SEQRES 25 A 444 ASP ILE MET HIS ASP TYR PRO SER ILE ARG GLU VAL TYR SEQRES 26 A 444 LEU ILE CYS ASN THR THR ASN LEU GLY VAL VAL ALA PRO SEQRES 27 A 444 LEU GLY TYR ASN GLY LEU LEU ILE LEU ALA CYS THR PHE SEQRES 28 A 444 TYR ALA PHE LYS THR ARG ASN VAL PRO ALA ASN PHE ASN SEQRES 29 A 444 GLU ALA LYS TYR ILE ALA PHE THR MET TYR THR THR CYS SEQRES 30 A 444 ILE ILE TRP LEU ALA PHE VAL PRO ILE TYR PHE GLY SER SEQRES 31 A 444 ASN TYR LYS ILE ILE THR MET CYS PHE SER VAL SER LEU SEQRES 32 A 444 SER ALA THR VAL ALA LEU GLY CYS MET PHE VAL PRO LYS SEQRES 33 A 444 VAL TYR ILE ILE LEU ALA LYS PRO GLU ARG ASN VAL ARG SEQRES 34 A 444 SER ALA ALA ALA ALA HIS HIS HIS HIS HIS HIS HIS HIS SEQRES 35 A 444 HIS HIS MODRES 4OO9 YCM A 634 CYS S-(2-AMINO-2-OXOETHYL)-L-CYSTEINE MODRES 4OO9 YCM A 691 CYS S-(2-AMINO-2-OXOETHYL)-L-CYSTEINE HET YCM A 634 10 HET YCM A 691 10 HET OLA A4001 20 HET OLA A4002 15 HET OLA A4003 14 HET OLA A4004 13 HET 2U8 A4005 23 HET MES A4006 12 HETNAM YCM S-(2-AMINO-2-OXOETHYL)-L-CYSTEINE HETNAM OLA OLEIC ACID HETNAM 2U8 MAVOGLURANT HETNAM MES 2-(N-MORPHOLINO)-ETHANESULFONIC ACID HETSYN YCM CYSTEINE-S-ACETAMIDE HETSYN 2U8 METHYL (3AR,4S,7AR)-4-HYDROXY-4-[(3-METHYLPHENYL) HETSYN 2 2U8 ETHYNYL]OCTAHYDRO-1H-INDOLE-1-CARBOXYLATE FORMUL 1 YCM 2(C5 H10 N2 O3 S) FORMUL 2 OLA 4(C18 H34 O2) FORMUL 6 2U8 C19 H23 N O3 FORMUL 7 MES C6 H13 N O4 S FORMUL 8 HOH *46(H2 O) HELIX 1 1 SER A 568 GLY A 576 1 9 HELIX 2 2 PRO A 578 TYR A 604 1 27 HELIX 3 3 THR A 607 SER A 612 1 6 HELIX 4 4 SER A 614 CYS A 631 1 18 HELIX 5 5 CYS A 631 ILE A 636 1 6 HELIX 6 6 LYS A 640 GLU A 1011 1 49 HELIX 7 7 SER A 1038 GLY A 1051 1 14 HELIX 8 8 THR A 1059 ARG A 1080 1 22 HELIX 9 9 LEU A 1084 LEU A 1091 1 8 HELIX 10 10 ASP A 1092 GLY A 1107 1 16 HELIX 11 11 GLY A 1107 ALA A 1112 1 6 HELIX 12 12 PHE A 1114 GLN A 1123 1 10 HELIX 13 13 ARG A 1125 ALA A 1134 1 10 HELIX 14 14 SER A 1136 THR A 1142 1 7 HELIX 15 15 THR A 1142 GLY A 1156 1 15 HELIX 16 16 ALA A 690 GLU A 715 1 26 HELIX 17 17 ASN A 737 THR A 761 1 25 HELIX 18 18 GLU A 770 GLY A 794 1 25 HELIX 19 19 TYR A 797 PHE A 818 1 22 HELIX 20 20 PHE A 818 LYS A 828 1 11 SHEET 1 A 3 TYR A1018 LYS A1019 0 SHEET 2 A 3 TYR A1025 ILE A1027 -1 O THR A1026 N TYR A1018 SHEET 3 A 3 HIS A1031 LEU A1032 -1 O HIS A1031 N ILE A1027 SSBOND 1 CYS A 644 CYS A 733 1555 1555 2.03 LINK C PHE A 633 N YCM A 634 1555 1555 1.33 LINK C YCM A 634 N LEU A 635 1555 1555 1.33 LINK C ALA A 690 N YCM A 691 1555 1555 1.33 LINK C YCM A 691 N ALA A 692 1555 1555 1.33 SITE 1 AC1 4 VAL A 741 GLY A 745 TRP A 785 PHE A 793 SITE 1 AC2 4 PRO A 569 VAL A 570 ILE A 581 OLA A4004 SITE 1 AC3 3 TYR A 645 VAL A 709 LYS A1048 SITE 1 AC4 7 PRO A 569 VAL A 584 CYS A 588 PHE A 633 SITE 2 AC4 7 ILE A 636 ALA A 637 OLA A4002 SITE 1 AC5 15 GLY A 624 ILE A 651 SER A 654 PRO A 655 SITE 2 AC5 15 SER A 658 TYR A 659 VAL A 740 PRO A 743 SITE 3 AC5 15 LEU A 744 ASN A 747 PHE A 788 SER A 805 SITE 4 AC5 15 VAL A 806 SER A 809 ALA A 813 SITE 1 AC6 8 TYR A 730 ILE A 732 ASN A 796 TYR A 797 SITE 2 AC6 8 LYS A 798 ILE A 799 TYR A1139 LYS A1147 CRYST1 143.242 43.555 82.049 90.00 99.37 90.00 C 1 2 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.006981 0.000000 0.001152 0.00000 SCALE2 0.000000 0.022959 0.000000 0.00000 SCALE3 0.000000 0.000000 0.012353 0.00000